Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 30.06 CNY 3.83% Market Closed
Market Cap: 13.6B CNY

Yipinhong Pharmaceutical Co Ltd
Investor Relations

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science.

The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Show more
Loading
300723
Shanghai Composite

Earnings Calls

No Earnings Calls Available

Management

Mr. Hanxiong Li
Chairman of the Board of Directors & GM
No Bio Available
Mr. Huixing Zhang
Chief Financial Officer
No Bio Available
Ms. Dongling Yang
Deputy GM & Non-Independent Director
No Bio Available
Mr. Mingyuan Zhang
Board Secretary
No Bio Available

Contacts

Address
GUANGDONG
Guangzhou
17-19F, Yunrun Mansion, No.27 Huanyu 1st Road, Guangzhou International Biological Island, Huangpu District
Contacts
+862028877623
www.gdyph.com